EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Risk of adverse pregnancy outcomes in patients with pregnancy-harmful rheumatic diseases: A retrospective study

Zhengyan Hu, Rujun Zeng, Jinbiao Han, Shuang Qin, Lang Qin

Placenta and Reproductive Medicine · 31.03.2026 · 5 (1) · 51-58

DOI: 10.54844/prm.2026.1172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta and Reproductive Medicine, online erschienen am 31.03.2026. Verfasst von Zhengyan Hu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the risks of adverse pregnancy outcomes (APOs) in pregnant women with different pregnancy-harmful rheumatic diseases (PH-RDs), including systemic lupus erythematosus (SLE), primary Sjögren's syndrome (pSS), obstetric antiphospholipid syndrome (OAPS), and undifferentiated connective tissue disease (UCTD).

Methods

Medical records for women confirmed of ongoing pregnancy at 20 weeks of gestation at West China Second University Hospital, Sichuan University from January 2018 to December 2023 were retrospectively scanned. Patients diagnosed of SLE, pSS, OAPS, and/or UCTD with singleton pregnancies were included. The primary outcomes were live birth rate, preterm birth rate, preeclampsia, and fetal growth restriction (FGR).

Results

A total of 102, 427 medical records were scanned for the study, resulting in the inclusion of 2518 patients with SLE (n = 281), pSS (n = 144), OAPS (n = 1870), UCTD (n = 175), or the combination of two of these PH-RDs (n = 48). For the difference between single and two combined PH-RDs, the live birth rate was comparable, and the incidence of preterm birth, preeclampsia, and FGR were significantly higher in the combined PH-RDs groups (P < 0.001, P = 0.009, P = 0.003). For the difference between different PH-RDs, the live birth rate in the OAPS group was significantly lower than in the UCTD group (P = 0.019). The incidence of preeclampsia was higher in the SLE group than in the pSS and UCTD groups (P = 0.004).

Conclusion

The effects of PH-RD on pregnancy are mainly seen in placenta-related APOs and complications such as preterm birth, preeclampsia, and FGR, especially SLE and OAPS. The combination of two PH-RDs may further affect the pregnancy outcomes.

Zitieren

APA

Hu, Z., Zeng, R., Han, J., Qin, S., & Qin, L. (2026). Risk of adverse pregnancy outcomes in patients with pregnancy-harmful rheumatic diseases: A retrospective study. Placenta and Reproductive Medicine, 5(1), 51-58. https://doi.org/10.54844/prm.2026.1172

Vancouver

Hu Z, Zeng R, Han J, Qin S, Qin L. Risk of adverse pregnancy outcomes in patients with pregnancy-harmful rheumatic diseases: A retrospective study. Placenta and Reproductive Medicine. 2026;5(1):51-58. doi:10.54844/prm.2026.1172

BibTeX
@article{Hu2026,
  author = {Hu, Zhengyan and Zeng, Rujun and Han, Jinbiao and Qin, Shuang and Qin, Lang},
  title = {Risk of adverse pregnancy outcomes in patients with pregnancy-harmful rheumatic diseases: A retrospective study},
  journal = {Placenta and Reproductive Medicine},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {51--58},
  doi = {10.54844/prm.2026.1172}
}
Kostenlos starten →